The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Fasifree 10% w/v Oral Suspension

10 percent weight/volume Oral suspension

Bimeda Animal Health LimitedVPA22033/020/001

Main Information

Trade NameFasifree 10% w/v Oral Suspension
Active SubstancesTriclabendazole
Strength10 percent weight/volume
Dosage FormOral suspension
Licence HolderBimeda Animal Health Limited
Licence NumberVPA22033/020/001

Group Information

ATC CodeQP52AC01 triclabendazole
Therapeutic ClassEndoparasiticide


Licence Issued22/02/2002
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back